{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:11:17Z","timestamp":1790813477531,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death worldwide. COPD is frequently punctuated by acute exacerbations that are precipitated primarily by infections, which increase both morbidity and mortality and inflates healthcare costs. Despite the significance of exacerbations, little understanding of immune function in COPD exacerbations exists. Natural killer (NK) cells are important effectors of innate and adaptive immune responses to pathogens and NK cell function is altered in smokers and COPD. Using high-dimensional flow cytometry, we phenotyped peripheral blood NK cells from never smokers, smokers, and COPD patients and employed a non-supervised clustering algorithm to define and detect changes in NK cell populations. We identified greater than 1,000 unique NK cell subpopulations across patient groups and describe 13 altered NK populations in patients who experienced prior exacerbations. Based upon cluster sizes and associated fluorescence data, we generated a logistic regression model to predict patients with a history of exacerbations with high sensitivity and specificity. Moreover, highly enriched NK cell subpopulations implicated in the regression model exhibited enhanced effector functions as defined by <jats:italic>in vitro<\/jats:italic> cytotoxicity assays. These novel data reflect the effects of smoking and disease on peripheral blood NK cell phenotypes, provide insight into the potential immune pathophysiology of COPD exacerbations, and indicate that NK cell phenotyping may be a useful and biologically relevant marker to predict COPD exacerbations.<\/jats:p>","DOI":"10.1038\/s41598-020-58326-7","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T11:02:44Z","timestamp":1580122964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Unique natural killer cell subpopulations are associated with exacerbation risk in chronic obstructive pulmonary disease"],"prefix":"10.1038","volume":"10","author":[{"given":"Andrew R.","family":"Osterburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph J.","family":"Panos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Borchers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,27]]},"reference":[{"key":"58326_CR1","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1183\/09031936.00142414","volume":"45","author":"PG Burney","year":"2015","unstructured":"Burney, P. G., Patel, J., Newson, R., Minelli, C. & Naghavi, M. Global and regional trends in COPD mortality, 1990\u20132010. Eur. Respir. J. 45, 1239\u20131247 (2015).","journal-title":"Eur. Respir. J."},{"key":"58326_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.rmed.2017.04.013","volume":"128","author":"DMG Halpin","year":"2017","unstructured":"Halpin, D. M. G. et al. Effect of a single exacerbation on decline in lung function in COPD. Respir. Med. 128, 85\u201391 (2017).","journal-title":"Respir. Med."},{"key":"58326_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2174\/156801005774912824","volume":"4","author":"TD Tetley","year":"2005","unstructured":"Tetley, T. D. Inflammatory cells and chronic obstructive pulmonary disease. Curr. Drug. Targets Inflamm. Allergy 4, 607\u2013618 (2005).","journal-title":"Curr. Drug. Targets Inflamm. Allergy"},{"key":"58326_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12931-016-0456-y","volume":"17","author":"JX Geerdink","year":"2016","unstructured":"Geerdink, J. X. et al. Differences in systemic adaptive immunity contribute to the \u2018frequent exacerbator\u2019 COPD phenotype. Respir. Res. 17, 140 (2016).","journal-title":"Respir. Res."},{"key":"58326_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1146\/annurev-immunol-020711-075053","volume":"30","author":"H Spits","year":"2012","unstructured":"Spits, H. & Cupedo, T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 30, 647\u2013675 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"58326_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/cyto.a.22740","volume":"89","author":"JA Rebhahn","year":"2016","unstructured":"Rebhahn, J. A. et al. Competitive SWIFT cluster templates enhance detection of aging changes. Cytometry A 89, 59\u201370 (2016).","journal-title":"Cytometry A"},{"key":"58326_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/cyto.a.22445","volume":"85","author":"TR Mosmann","year":"2014","unstructured":"Mosmann, T. R. et al. SWIFT-scalable clustering for automated identification of rare cell populations in large, high-dimensional flow cytometry datasets, part 2: biological evaluation. Cytometry A 85, 422\u2013433 (2014).","journal-title":"Cytometry A"},{"key":"58326_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/cyto.a.22446","volume":"85","author":"I Naim","year":"2014","unstructured":"Naim, I. et al. SWIFT-scalable clustering for automated identification of rare cell populations in large, high-dimensional flow cytometry datasets, part 1: algorithm design. Cytometry A 85, 408\u2013421 (2014).","journal-title":"Cytometry A"},{"key":"58326_CR9","doi-asserted-by":"publisher","first-page":"208ra145","DOI":"10.1126\/scitranslmed.3006702","volume":"5","author":"A Horowitz","year":"2013","unstructured":"Horowitz, A. et al. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci. Transl. Med. 5, 208ra145 (2013).","journal-title":"Sci. Transl. Med."},{"key":"58326_CR10","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1002\/eji.200425418","volume":"34","author":"C Vitale","year":"2004","unstructured":"Vitale, C. et al. The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and\/or dysfunction of triggering receptors involved in natural cytotoxicity. Eur. J. Immunol. 34, 3028\u20133038 (2004).","journal-title":"Eur. J. Immunol."},{"key":"58326_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trim.2016.04.008","volume":"37","author":"CM Michelo","year":"2016","unstructured":"Michelo, C. M. et al. Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation. Transpl. Immunol. 37, 1\u20139 (2016).","journal-title":"Transpl. Immunol."},{"key":"58326_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2172-6-13","volume":"6","author":"HT Maecker","year":"2005","unstructured":"Maecker, H. T. et al. Standardization of cytokine flow cytometry assays. BMC Immunol. 6, 13 (2005).","journal-title":"BMC Immunol."},{"key":"58326_CR13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","volume":"112","author":"MA Caligiuri","year":"2008","unstructured":"Caligiuri, M. A. Human natural killer cells. Blood 112, 461\u2013469 (2008).","journal-title":"Blood"},{"key":"58326_CR14","doi-asserted-by":"publisher","first-page":"14725","DOI":"10.1073\/pnas.1110900108","volume":"108","author":"S Lopez-Verges","year":"2011","unstructured":"Lopez-Verges, S. et al. Expansion of a unique CD57(+)NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl Acad. Sci. USA 108, 14725\u201314732 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58326_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature07665","volume":"457","author":"JC Sun","year":"2009","unstructured":"Sun, J. C., Beilke, J. N. & Lanier, L. L. Adaptive immune features of natural killer cells. Nat. 457, 557\u2013561 (2009).","journal-title":"Nat."},{"key":"58326_CR16","doi-asserted-by":"publisher","first-page":"e61024","DOI":"10.1371\/journal.pone.0061024","volume":"8","author":"J Jin","year":"2013","unstructured":"Jin, J. et al. CD11b(\u2212)CD27(\u2212) NK cells are associated with the progression of lung carcinoma. PLoS One 8, e61024 (2013).","journal-title":"PLoS One"},{"key":"58326_CR17","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1182\/blood-2005-08-3504","volume":"107","author":"S Chiesa","year":"2006","unstructured":"Chiesa, S. et al. Multiplicity and plasticity of natural killer cell signaling pathways. Blood 107, 2364\u20132372 (2006).","journal-title":"Blood"},{"key":"58326_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.it.2015.03.006","volume":"36","author":"H Peng","year":"2015","unstructured":"Peng, H. & Tian, Z. Re-examining the origin and function of liver-resident NK cells. Trends Immunol. 36, 293\u2013299 (2015).","journal-title":"Trends Immunol."},{"key":"58326_CR19","doi-asserted-by":"publisher","first-page":"4460","DOI":"10.4049\/jimmunol.0903654","volume":"184","author":"GT Motz","year":"2010","unstructured":"Motz, G. T. et al. Chronic cigarette smoke exposure primes NK cell activation in a mouse model of chronic obstructive pulmonary disease. J. Immunol. 184, 4460\u20134469 (2010).","journal-title":"J. Immunol."},{"key":"58326_CR20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.18632\/oncotarget.13613","volume":"8","author":"F Qiu","year":"2017","unstructured":"Qiu, F. et al. Impacts of cigarette smoking on immune responsiveness: Up and down or upside down? Oncotarget 8, 268\u2013284 (2017).","journal-title":"Oncotarget"},{"key":"58326_CR21","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1182\/blood-2010-04-282301","volume":"116","author":"S Lopez-Verges","year":"2010","unstructured":"Lopez-Verges, S. et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 116, 3865\u20133874 (2010).","journal-title":"Blood"},{"key":"58326_CR22","first-page":"39","volume":"27","author":"J Olloquequi","year":"2012","unstructured":"Olloquequi, J. et al. Lung CD57+ cell density is increased in very severe COPD. Histol. Histopathol. 27, 39\u201347 (2012).","journal-title":"Histol. Histopathol."},{"key":"58326_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1183\/09031936.00201509","volume":"37","author":"J Olloquequi","year":"2011","unstructured":"Olloquequi, J. et al. Significant increase of CD57+ cells in pulmonary lymphoid follicles of COPD patients. Eur. Respir. J. 37, 289\u2013298 (2011).","journal-title":"Eur. Respir. J."},{"key":"58326_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2036.1995.tb00367.x","volume":"9","author":"AJ Van Ierssel","year":"1995","unstructured":"Van Ierssel, A. J. et al. Budesonide and prednisolone suppress peripheral blood natural killer cells in Crohn\u2019s disease. Aliment. Pharmacol. Ther. 9, 173\u2013178 (1995).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"58326_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/srep23002","volume":"6","author":"MJ Olnes","year":"2016","unstructured":"Olnes, M. J. et al. Effects of Systemically Administered Hydrocortisone on the Human Immunome. Sci. Rep. 6, 23002 (2016).","journal-title":"Sci. Rep."},{"key":"58326_CR26","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","volume":"184","author":"M Bafadhel","year":"2011","unstructured":"Bafadhel, M. et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am. J. Respir. Crit. Care Med. 184, 662\u2013671 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"58326_CR27","first-page":"157","volume":"6","author":"A Lacoma","year":"2011","unstructured":"Lacoma, A. et al. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease. Int. J. Chron. Obstruct Pulmon Dis. 6, 157\u2013169 (2011).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"58326_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3109\/15412555.2013.829436","volume":"11","author":"S Nikolakopoulou","year":"2014","unstructured":"Nikolakopoulou, S. et al. Serum angiopoietin-2 and CRP levels during COPD exacerbations. COPD 11, 46\u201351 (2014).","journal-title":"COPD"},{"key":"58326_CR29","doi-asserted-by":"crossref","unstructured":"Chen, Y. W., Leung, J. M. & Sin, D. D. A Systematic Review of Diagnostic Biomarkers of COPD Exacerbation. PLoS One 11 (2016).","DOI":"10.1371\/journal.pone.0158843"},{"key":"58326_CR30","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","volume":"363","author":"JR Hurst","year":"2010","unstructured":"Hurst, J. R. et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N. Engl. J. Med. 363, 1128\u20131138 (2010).","journal-title":"N. Engl. J. Med."},{"key":"58326_CR31","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1164\/rccm.201810-1860SO","volume":"199","author":"RA Stockley","year":"2019","unstructured":"Stockley, R. A., Halpin, D. M. G., Celli, B. R. & Singh, D. Chronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation. Am. J. Respir. Crit. Care Med. 199, 1195\u20131204 (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"58326_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/immu.200390014","volume":"33","author":"T Bauernhofer","year":"2003","unstructured":"Bauernhofer, T., Kuss, I., Henderson, B., Baum, A. S. & Whiteside, T. L. Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer. Eur. J. Immunol. 33, 119\u2013124 (2003).","journal-title":"Eur. J. Immunol."},{"key":"58326_CR33","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1164\/ajrccm.163.5.2101039","volume":"163","author":"RA Pauwels","year":"2001","unstructured":"Pauwels, R. A. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 163, 1256\u20131276 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"58326_CR34","doi-asserted-by":"crossref","unstructured":"Vogelmeier, C. F. et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Eur Respir J 49 (2017).","DOI":"10.1183\/13993003.50214-2017"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58326-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58326-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58326-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:00:13Z","timestamp":1670306413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58326-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["58326"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-58326-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,27]]},"assertion":[{"value":"12 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1238"}}